Literature DB >> 10471349

Trace amounts of albumin protect against ischemia and reperfusion injury in isolated rat hearts.

J A Watts1, P C Maiorano.   

Abstract

Albumin is used to provide colloid osmotic pressure in some resuscitation and organ preservation protocols. These solutions are expensive and carry the risks of using high concentrations of blood products. Used as a carrier of drugs and substrates, the concentration of albumin present in perfusates may be considerably lower in experimental ischemia. The present study examined if trace amounts of albumin (0.0004%) reduce injury from ischemia and reperfusion in isolated rat hearts. Hearts were perfused by the Langendorff technique (60 mmHg) with an intraventricular balloon. Zero-flow ischemia (20 min, 37 degrees C) was followed by reperfusion (35 min, 37 degrees C). Recovery of contractile function during reperfusion was significantly improved by the presence of fatty acid-free bovine serum albumin (BSA) (22 290+/-1280 mmHg/min, pressure-rate product) or rat serum albumin (RSA) (21 095+/-2836 mmHg/min) compared with Krebs-Henseleit buffer with no albumin (KHB) (9660+/-2324 mmHg/min). Release of lactate dehydrogenase activity, formation of tissue edema and accumulation of tissue malonyldialdehyde were significantly reduced in hearts receiving BSA or RSA compared with KHB alone. These parameters were not altered by the presence of albumin in non-ischemic control hearts or in the pre-ischemic values of the hearts subjected to ischemia and reperfusion. Development of ischemic contracture with an extended period of ischemia (27 min) was not altered by the presence of BSA, suggesting that protection observed with albumin occurred during reperfusion, rather than during ischemia. Reperfusion following 45 min of ischemia with bovine serum albumin resulted in similar myocardial injury to hearts that were reperfused following 20 min of ischemia without bovine serum albumin. Thus, trace amounts of albumin provide significant reduction in myocardial injury from ischemia and reperfusion, probably via antioxidant mechanisms. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471349     DOI: 10.1006/jmcc.1999.1001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts.

Authors:  Ya-Jian Cheng; Di Lang; Shelton D Caruthers; Igor R Efimov; Junjie Chen; Samuel A Wickline
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-09       Impact factor: 4.733

2.  Prognostic significance of serum antioxidant parameters in immunocompetent patients with cryptococcal meningitis.

Authors:  Y Liu; Y Jiang; A Wu; S Chen; Y Zhang; M Liu; X Ma; L Ma; X Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-06       Impact factor: 3.267

3.  Can albumin administration relieve lung injury in trauma/hemorrhagic shock?

Authors:  Zuo-Bing Chen; Zi-Wei Wang; Chen-Yan Ding; Jian-Hua Yan; Yuan Gao; Yun Zhang; Lin-Mei Ni; Yong-Qing Zhou
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

4.  Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts.

Authors:  Ségolène Gambert; Catherine Vergely; Rodolphe Filomenko; Daniel Moreau; Ali Bettaieb; Lionel H Opie; Luc Rochette
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

5.  Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning.

Authors:  Nilguen Gedik; Leonardo Maciel; Christiane Schulte; Andreas Skyschally; Gerd Heusch; Petra Kleinbongard
Journal:  Arch Med Sci       Date:  2016-08-16       Impact factor: 3.318

6.  Glycation abolishes the cardioprotective effects of albumin during ex vivo ischemia-reperfusion.

Authors:  Rudo F Mapanga; Danzil E Joseph; Marco Saieva; Florence Boyer; Philippe Rondeau; Emmanuel Bourdon; M Faadiel Essop
Journal:  Physiol Rep       Date:  2017-01-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.